Update on head neck cancer management

8th December 2017  08:00 AM - 05:00 PM (GMT+00:00) GMT

This event will provide an update on the management of head and neck cancer, including new innovative treatments such as immunotherapy. It will cover all the most relevant diagnostic and management advances in head neck cancer and will be useful to any members of the multi-professional disciplines involved in its management. It will also include lesser discussed topics such as salivary gland tumours, which although less common have gone through a research renaissance.

There will be high quality talks and stimulating debates from some of Europe's best head and neck cancer speakers.

Educational aims:
  • Provide an update for all multidisciplinary professionals working with head neck cancer patients
  • Increase education for lesser-known head and neck sites such as salivary gland tumours
  • Discuss the most recent advances in the management of head and neck cancer
  • Stimulate debate in new management models for head and neck cancer
  • Debate the most contentious points in head and neck cancer allowing for further reflection and enquiry

Click here for the programme

Registration Fees
Non member £250
BIR Member Plan 1 £145
BIR Member Plan 2 £110
BIR Trainee member £65
BIR Retired/Student member £55

Venue

Speakers

Sponsors

Bayer

The NHS faces many challenges today around the increasing need for governance to demonstrate best patient care within increasing financial constraints. Bayer’s Radiology business is well placed to be the partner in helping trusts to address these challenges. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 01635 563999 www.radiology.bayer.co.uk

Siemens Healthcare

Siemens Healthineers enables healthcare providers around the world to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in both its core areas in imaging for diagnostic and therapeutic purposes as well as in laboratory diagnostics and molecular medicine. Siemens Healthineers is also continuously developing its digital health services and hospital management offerings, working closely with operators to develop common fields of business and to help them to not only minimise their risks, but also to exploit new opportunities. For further information visit www.siemens.co.uk.healthineers